Table of Contents
ISRN Genomics
Volume 2013 (2013), Article ID 921418, 18 pages
http://dx.doi.org/10.1155/2013/921418
Review Article

Critical Analysis of Strand-Biased Somatic Mutation Signatures in TP53 versus Ig Genes, in Genome-Wide Data and the Etiology of Cancer

1Melville Analytics Pty. Ltd., Unit 14, Nuggets Crossing, Jindabyne, NSW 2627, Australia
2School of Veterinary and Biomedical Sciences, Murdoch University, South Street, Murdoch, WA 6150, Australia

Received 4 September 2012; Accepted 23 October 2012

Academic Editors: S. N. Shchelkunov and A. Stubbs

Copyright © 2013 Robyn A. Lindley and Edward J. Steele. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Soussi, “Advances in carcinogenesis: a historical perspective from observational studies to tumor genome sequencing and TP53 mutation spectrum analysis,” Biochimica et Biophysica Acta, vol. 1816, no. 2, pp. 199–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Hainaut and G. P. Pfeifer, “Patterns of p53→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke,” Carcinogenesis, vol. 22, no. 3, pp. 367–374, 2001. View at Google Scholar · View at Scopus
  3. E. J. Steele, “Mechanism of somatic hypermutation: critical analysis of strand biased mutation signatures at A:T and G:C base pairs,” Molecular Immunology, vol. 46, no. 3, pp. 305–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. J. Steele and R. A. Lindley, “Somatic mutation patterns in non-lymphoid cancers resemble the strand biased somatic hypermutation spectra of antibody genes,” DNA Repair, vol. 9, no. 6, pp. 600–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Wu and Z. Li, “Human polynucleotide phosphorylase reduces oxidative RNA damage and protects HeLa cell against oxidative stress,” Biochemical and Biophysical Research Communications, vol. 372, no. 2, pp. 288–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Kuraoka, M. Endou, Y. Yamaguchi, T. Wada, H. Handa, and K. Tanaka, “Effects of endogenous DNA base lesions on transcription elongation by mammalian RNA polymerase II. Implications for transcription-coupled DNA repair and transcriptional mutagenesis,” Journal of Biological Chemistry, vol. 278, no. 9, pp. 7294–7299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Franklin, P. J. Milburn, R. V. Blanden, and E. J. Steele, “Human DNA polymerase-η, an A-T mutator in somatic hypermutation of rearranged immunoglobulin genes, is a reverse transcriptase,” Immunology and Cell Biology, vol. 82, no. 2, pp. 219–225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. E. J. Steele, R. A. Lindley, J. Wen, and G. F. Weiller, “Computational analyses show A-to-G mutations correlate with nascent mRNA hairpins at somatic hypermutation hotspots,” DNA Repair, vol. 5, no. 11, pp. 1346–1363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. B. Winter, Q. H. Phung, X. Zeng et al., “Normal somatic hypermutation of Ig genes in the absence of 8-hydroxyguanine-DNA glycosylase,” Journal of Immunology, vol. 170, no. 11, pp. 5558–5562, 2003. View at Google Scholar · View at Scopus
  10. C. Rada, G. T. Williams, H. Nilsen, D. E. Barnes, T. Lindahl, and M. S. Neuberger, “Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice,” Current Biology, vol. 12, no. 20, pp. 1748–1755, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Rada, J. M. Di Noia, and M. S. Neuberger, “Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation,” Molecular Cell, vol. 16, no. 2, pp. 163–171, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Zeng, D. B. Winter, C. Kasmer, K. H. Kraemer, A. R. Lehmann, and P. J. Gearhart, “DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes,” Nature Immunology, vol. 2, no. 6, pp. 537–541, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Delbos, S. Aoufouchi, A. Faili, J. C. Weill, and C. A. Reynaud, “DNA polymerase η is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse,” Journal of Experimental Medicine, vol. 204, no. 1, pp. 17–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Schenten, V. L. Gerlach, C. Guo et al., “DNA polymerase K deficiency does not affect somatic hypermutation in mice,” European Journal of Immunology, vol. 32, no. 11, pp. 3152–3160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. McDonald, E. G. Frank, B. S. Plosky et al., “129-Derived strains of mice are deficient in DNA polymerase ι and have normal immunoglobulin hypermutation,” Journal of Experimental Medicine, vol. 198, no. 4, pp. 635–643, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Faili, A. Stary, F. Delbos et al., “A backup role of DNA polymerase κ in Ig gene hypermutation only takes place in the complete absence of DNA polymerase η,” Journal of Immunology, vol. 182, no. 10, pp. 6353–6359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Longerich, L. Meira, D. Shah, L. D. Samson, and U. Storb, “Alkyladenine DNA glycosylase (Aag) in somatic hypermutation and class switch recombination,” DNA Repair, vol. 6, no. 12, pp. 1764–1773, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Ratnam, G. Bozek, D. Nicolae, and U. Storb, “The pattern of somatic hypermutation of Ig genes is altered when p53 is inactivated,” Molecular Immunology, vol. 47, no. 16, pp. 2611–2618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. G. Jansen, P. Langerak, A. Tsaalbi-Shtylik, P. Van Den Berk, H. Jacobs, and N. De Wind, “Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice,” Journal of Experimental Medicine, vol. 203, no. 2, pp. 319–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Saribasak, R. W. Maul, Z. Cao et al., “DNA polymerase ζ generates tandem mutations in immunoglobulin variable regions,” Journal of Experimental Medicine, vol. 209, no. 6, pp. 1075–1081, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. C. L. Beale, S. K. Petersen-Mahrt, I. N. Watt, R. S. Harris, C. Rada, and M. S. Neuberger, “Comparison of the different context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo,” Journal of Molecular Biology, vol. 337, no. 3, pp. 585–596, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Nik-Zainal, L. B. Alexandrov, D. C. Wedge, P. Van Loo, C. D. Greenman, and K. Raine, “Mutational processes molding the genomes of 21 breast cancers,” Cell, vol. 149, no. 5, pp. 979–993, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Di Noia and M. S. Neuberger, “Molecular mechanisms of antibody somatic hypermutation,” Annual Review of Biochemistry, vol. 76, pp. 1–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Teng and F. N. Papavasiliou, “Immunoglobulin somatic hypermutation,” Annual Review of Genetics, vol. 41, pp. 107–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. I. M. Okazaki, H. Hiai, N. Kakazu et al., “Constitutive expression of AID leads to tumorigenesis,” Journal of Experimental Medicine, vol. 197, no. 9, pp. 1173–1181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. H. D. Morgan, W. Dean, H. A. Coker, W. Reik, and S. K. Petersen-Mahrt, “Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming,” Journal of Biological Chemistry, vol. 279, no. 50, pp. 52353–52360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Honjo, M. Kobayashi, N. Begum, A. Kotani, S. Sabouri, and H. Nagaoka, “The AID Dilemma. Infection, or Cancer?” Advances in Cancer Research, vol. 113, pp. 1–44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. G. P. Pfeifer and A. Besaratinia, “Mutational spectra of human cancer,” Human Genetics, vol. 125, no. 5-6, pp. 493–506, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. G. B. Golding, P. J. Gearhart, and B. W. Glickman, “Patterns of somatic mutations in immunoglobulin variable genes,” Genetics, vol. 115, no. 1, pp. 169–176, 1987. View at Google Scholar · View at Scopus
  30. E. J. Steele, A. Franklin, and R. V. Blanden, “Genesis of the strand-biased signature in somatic hypermutation of rearranged immunoglobulin variable genes,” Immunology and Cell Biology, vol. 82, no. 2, pp. 209–218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Zylstra, H. S. Rothenfluh, G. F. Weiller, R. V. Blanden, and E. J. Steele, “PCR amplification of murine immunoglobulin germline V genes: strategies for minimization of recombination artefacts,” Immunology and Cell Biology, vol. 76, no. 5, pp. 395–405, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. R. V. Blanden and E. J. Steele, “Misinterpretation of DNA sequence data generated by polymerase chain reactions,” Molecular Immunology, vol. 37, no. 6, p. 329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. M. F. Goodman, “Error-prone repair DNA polymerases in prokaryotes and eukaryotes,” Annual Review of Biochemistry, vol. 71, pp. 17–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. E. J. Steele and J. W. Pollard, “Hypothesis: somatic hypermutation by gene conversion via the error prone DNA → RNA → DNA information loop,” Molecular Immunology, vol. 24, no. 6, pp. 667–673, 1987. View at Google Scholar · View at Scopus
  35. P. C. Hanawalt and G. Spivak, “Transcription-coupled DNA repair: two decades of progress and surprises,” Nature Reviews Molecular Cell Biology, vol. 9, no. 12, pp. 958–970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. E. J. Steele, J. F. Williamson, S. Lester et al., “Genesis of ancestral haplotypes: RNA modifications and reverse transcription-mediated polymorphisms,” Human Immunology, vol. 72, no. 3, pp. 283–293, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Thorslund, M. Sunesen, V. A. Bohr, and T. Stevnsner, “Repair of 8-oxoG is slower in endogenous nuclear genes than in mitochondrial DNA and is without strand bias,” DNA Repair, vol. 1, no. 4, pp. 261–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Matsuda, K. Ishii, P. Bourvagnet et al., “The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus,” Journal of Experimental Medicine, vol. 188, no. 11, pp. 2151–2162, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. B. L. Bass, “RNA editing by adenosine deaminases that act on RNA,” Annual Review of Biochemistry, vol. 71, pp. 817–846, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Herbert, J. Alfken, Y. G. Kim, I. S. Mian, K. Nishikura, and A. Rich, “A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 16, pp. 8421–8426, 1997. View at Google Scholar · View at Scopus
  41. A. Herbert and A. Rich, “The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 21, pp. 12132–12137, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. Q. Wang, M. Miyakoda, W. Yang et al., “Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene,” Journal of Biological Chemistry, vol. 279, no. 6, pp. 4952–4961, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Paus, G. P. Tri, T. D. Chan, S. Gardam, A. Basten, and R. Brink, “Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation,” Journal of Experimental Medicine, vol. 203, no. 4, pp. 1081–1091, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Gallo and F. Locatelli, “Adars: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1,” Biological Reviews, vol. 87, pp. 95–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Dominissini, S. Moshitch-Moshkovitz, N. Amariglio, and G. Rechavi, “Adenosine-to-inosine RNA editing meets cancer,” Carcinogenesis, vol. 32, no. 11, pp. 1569–1577, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Olivier, M. Hollstein, and P. Hainaut, “TP53 mutations in human cancers: origins, consequences, and clinical use,” in Additional Perspectives on the p53 Family, A. J. Levine and D. Lane, Eds., vol. 2, a001008 of Cold Spring Harbor Perspectives in Biology, pp. 1–17, 2010. View at Google Scholar
  47. A. Petitjean, E. Mathe, S. Kato et al., “Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database,” Human Mutation, vol. 28, no. 6, pp. 622–629, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. S. Hecht, “Tobacco carcinogens, their biomarkers and tobacco-induced cancer,” Nature Reviews Cancer, vol. 3, no. 10, pp. 733–744, 2003. View at Google Scholar · View at Scopus
  49. M. S. Greenblatt, W. P. Bennett, M. Hollstein, and C. C. Harris, “Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis,” Cancer Research, vol. 54, no. 18, pp. 4855–4878, 1994. View at Google Scholar · View at Scopus
  50. M. F. Denissenko, A. Pao, M. S. Tang, and G. P. Pfeifer, “Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53,” Science, vol. 274, no. 5286, pp. 430–432, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. M. F. Denissenko, A. Pao, G. P. Pfeifer, and M. S. Tang, “Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers,” Oncogene, vol. 16, no. 10, pp. 1241–1247, 1998. View at Google Scholar · View at Scopus
  52. E. D. Pleasance, P. J. Stephens, S. O'Meara et al., “A small-cell lung cancer genome with complex signatures of tobacco exposure,” Nature, vol. 463, no. 7278, pp. 184–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. S. A. Martomo and P. J. Gearhart, “Somatic hypermutation: subverted DNA repair,” Current Opinion in Immunology, vol. 18, no. 3, pp. 243–248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. T. M. Wilson, A. Vaisman, S. A. Martomo et al., “MSH2-MSH6 stimulates DNA polymerase η, suggesting a role for A:T mutations in antibody genes,” Journal of Experimental Medicine, vol. 201, no. 4, pp. 637–645, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. A. M. Bellizzi and W. L. Frankel, “Colorectal cancer due to deficiency in DNA mismatch repair function: a review,” Advances in Anatomic Pathology, vol. 16, no. 6, pp. 405–417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. L. D. Wood, D. W. Parsons, S. Jones et al., “The genomic landscapes of human breast and colorectal cancers,” Science, vol. 318, no. 5853, pp. 1108–1113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Greenman, P. Stephens, R. Smith et al., “Patterns of somatic mutation in human cancer genomes,” Nature, vol. 446, no. 7132, pp. 153–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Takai, H. Marusawa, and T. Chiba, “Acquisition of genetic aberrations by activation-induced cytidine deaminase (AID) during inflammation-associated carcinogenesis,” Cancers, vol. 3, no. 2, pp. 2750–2766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. S. K. Petersen-Mahrt, H. A. Coker, and S. Pauklin, “DNA deaminases: AIDing hormones in immunity and cancer,” Journal of Molecular Medicine, vol. 87, no. 9, pp. 893–897, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Pauklin, I. V. Sernández, G. Bachmann, A. R. Ramiro, and S. K. Petersen-Mahrt, “Estrogen directly activates AID transcription and function,” Journal of Experimental Medicine, vol. 206, no. 1, pp. 99–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. R. W. Maul and P. J. Gearhart, “Women, autoimmunity, and cancer: a dangerous liaison between estrogen and activation-induced deaminase?” Journal of Experimental Medicine, vol. 206, no. 1, pp. 11–13, 2009. View at Publisher · View at Google Scholar · View at Scopus